Gelonghui May 12 丨 Baicheng Pharmaceutical (301096onlinerussianroulette.SZ) announcedonlinerussianrouletteZhejiang Thermo Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received a clinical trial approval notice from the State Food and Drug Administration (NMPA). The bios2207 drug independently developed by the company will conduct clinical trial research. BIOS2207 is indicated for the treatment of adults and children 4 years of age and older with partial seizures (with or without secondary generalized seizures).